4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0000899243-22-031089
10% owner sold 128,285 shares at an average $5.27 ($675,507)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Havencrest Healthcare Partners, L.P. 10% owner | 2022-09-12 | Sale | −38,000 | $5.52 | $209,760 | 15,092,329 | I: show line 1 in the form |
| Havencrest Healthcare Partners, L.P. 10% owner | 2022-09-13 | Sale | −52,500 | $5.28 | $277,200 | 15,039,829 | I: show line 2 in the form |
| Havencrest Healthcare Partners, L.P. 10% owner | 2022-09-14 | Sale | −37,785 | $4.99 | $188,547 | 15,002,044 | I: show line 3 in the form |
| Open-market sales · 128,285 sh · avg $5.27 · $675,507 | |||||||
Loading xslF345X03/doc4.xml…